Form D · Pharmaceuticals
Saptalis Pharmaceuticals, LLC
Hauppauge, NY · CIK 0001646767
Offering snapshot reported Nov 8, 2016 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 8, 2016 | Initial | $6,500,000 | No comparison | 7 | SEC filing |
| Sep 11, 2015 | Initial | $3,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-274033
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NONE | None |
Source: Form D, filed Nov 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tatiana Akimova | Director, Executive |
| Polireddy Dondeti | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
45 Davids Drive
Hauppauge, NY, 11788
Hauppauge, NY, 11788